2,111 research outputs found
Meiyingia jinyunensis Li & Chen, 2015 in Li, Tian & Chen 2015
No full textMeiyingia jinyunensis Li & Chen, 2015 in Li, Tian & Chen, 2015: 596, figs.1–3. (Figs. 35a, b) Type locality: China, Chongqing, Beibei, Mt. Jinyunshan. Gender: male. Altitude: 568m. Date collected: 2011.IV.24 Collector: Shu-Qing SHI. Paratypes: 1 female, same data with holotype (SWU); 1 male, same data with holotype but 2012. IV. 20 (SWU).Published as part of Li, Zhu & Chen, Li, 2020, Primary types of longhorned beetles (Coleoptera, Cerambycidae, Vesperidae and Disteniidae) of Southwest University (SWU), pp. 25-46 in Zootaxa 4718 (1) on page 34, DOI: 10.11646/zootaxa.4718.1.2, http://zenodo.org/record/360220
Supporting_Information – Supplemental material for Theoretical studies of reaction mechanisms for potential reactions of HNCO with HO2 radicals
No full textSupplemental material, Supporting_Information for Theoretical studies of reaction mechanisms for potential reactions of HNCO with HO2 radicals by Beibei An, Fuhua Huang, Ke Chen, Jiamin Jiang, Jianbin Xu and Li Wang in Journal of Chemical Research</p
sj-pdf-1-jcm-10.1177_00219983211052604 – Supplemental Material for Probing the charge injection and dissipation in graphene oxide–epoxy composite
No full textSupplemental Material, sj-pdf-1-jcm-10.1177_00219983211052604 for Probing the charge injection and dissipation in graphene oxide–epoxy composite by Beibei Jia, Yuqing Chen, Chengxiang Chen, Yongfei Li, Wanli Ma, Xuzheng Zhang, Jun Zhou, Yang Wang, Yingye Jiang and Kai Wu in Journal of Composite Materials</p
Replication Data for: Comparison between PS-InSAR and leveling monitoring results
No full textThe dataset includes GPS data for InSAR results validation
sj-tiff-1-tag-10.1177_17562848241245455 – Supplemental material for In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer
No full textSupplemental material, sj-tiff-1-tag-10.1177_17562848241245455 for In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer by Hui Wang, Caiyun Nie, Weifeng Xu, Jing Li, He Gou, Huifang Lv, Beibei Chen, Jianzheng Wang, Yingjun Liu, Yunduan He, Jing Zhao and Xiaobing Chen in Therapeutic Advances in Gastroenterology</p
Hourly operation strategy of a CCHP system with GSHP and thermal energy storage (TES) under variable loads: a case study
No full textAbstract not availableWei Liu, Guanyi Chen, Beibei Yan, Zhihua Zhou, Haowei Du, Jian Zu
Guan yu gong ren he gong si jin rong de yan jiu
No full textShen, Beibei.Thesis Ph.D. Chinese University of Hong Kong 2015.Includes bibliographical references.Abstracts also in Chinese.Title from PDF title page (viewed on 02, November, 2016).Shen, Beibei
sj-docx-1-dhj-10.1177_20552076241239182 - Supplemental material for Comparative effectiveness of interventions on promoting physical activity in older adults: A systematic review and network meta-analysis
No full textSupplemental material, sj-docx-1-dhj-10.1177_20552076241239182 for Comparative effectiveness of interventions on promoting physical activity in older adults: A systematic review and network meta-analysis by Shuang Wu, Guangkai Li, Beibei Shi, Hongli Ge, Si Chen, Xianliang Zhang and Qiang He in DIGITAL HEALTH</p
sj-docx-2-tab-10.1177_1759720X211067304 – Supplemental material for Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study
No full textSupplemental material, sj-docx-2-tab-10.1177_1759720X211067304 for Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study by Honghu Tang, Beibei Cui, Yiyu Chen, Lin Chen, Zhihong Wang, Ning Zhang, Yanlan Yang, Xiaodong Wang, Xiangliang Xie, Lingyun Sun, Wantai Dang, Xianyang Wang, Runzi Li, Jianjun Zou, Yi Zhao and Yi Liu in Therapeutic Advances in Musculoskeletal Disease</p
sj-docx-1-tab-10.1177_1759720X211067304 – Supplemental material for Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study
No full textSupplemental material, sj-docx-1-tab-10.1177_1759720X211067304 for Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study by Honghu Tang, Beibei Cui, Yiyu Chen, Lin Chen, Zhihong Wang, Ning Zhang, Yanlan Yang, Xiaodong Wang, Xiangliang Xie, Lingyun Sun, Wantai Dang, Xianyang Wang, Runzi Li, Jianjun Zou, Yi Zhao and Yi Liu in Therapeutic Advances in Musculoskeletal Disease</p
- …
